Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Rituximab in Relapsed AIDS-Related NHL
NCT00183976Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Apr 2005
- Primary completion
- Sep 2005
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in AIDS-related lymphoma, non-Hodgkin lymphoma (NHL), Burkitt lymphoma (BL), primary effusion lymphoma (PEL), sponsored by University of Southern California. Started Apr 2005; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
AIDS-related lymphomanon-Hodgkin lymphoma (NHL)Burkitt lymphoma (BL)primary effusion lymphoma (PEL)
Beyond the preview
Go deeper on NCT00183976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183976.